loxiglumide has been researched along with Obesity in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Feinle-Bisset, C; Horowitz, M; Little, TJ | 1 |
| Jansen, JB; Lamers, CB; Lieverse, RJ; Masclee, AA; Rovati, LC | 1 |
| Herberg, L; Klonowski-Stumpe, H; Meereis-Schwanke, K; Niederau, C | 2 |
1 review(s) available for loxiglumide and Obesity
| Article | Year |
|---|---|
Role of cholecystokinin in appetite control and body weight regulation.
Topics: Animals; Appetite; Body Weight; Cholecystokinin; Digestive System Physiological Phenomena; Energy Intake; Gastrointestinal Hormones; Hormone Antagonists; Humans; Obesity; Proglumide; Receptors, Cholecystokinin | 2005 |
1 trial(s) available for loxiglumide and Obesity
| Article | Year |
|---|---|
Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women.
Topics: Adult; Appetite; Double-Blind Method; Female; Humans; Hunger; Infusions, Intravenous; Middle Aged; Obesity; Proglumide; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Satiety Response | 1995 |
2 other study(ies) available for loxiglumide and Obesity
| Article | Year |
|---|---|
CCK-resistance in Zucker obese versus lean rats.
Topics: Amylases; Animals; Capsaicin; Cholecystokinin; Eating; Female; Injections, Subcutaneous; Male; Obesity; Proglumide; Rats; Rats, Zucker; Receptors, Cholecystokinin | 1997 |
Long-term effects of CCK-agonist and -antagonist on food intake and body weight in Zucker lean and obese rats.
Topics: Animals; Body Weight; Ceruletide; Cholecystokinin; Drug Resistance; Eating; Female; Male; Obesity; Organ Size; Pancreas; Proglumide; Rats; Rats, Zucker; Receptor, Cholecystokinin A; Receptors, Cholecystokinin; Satiety Response | 1998 |